Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Tea tree oil (Melaleuca alternifolia) has been investigated for its antimicrobial properties, including activity against Staphylococcus aureus, the bacterium responsible for many staph infections. In vitro studies consistently show that tea tree oil exhibits significant antibacterial activity against both methicillin-sensitive and methicillin-resistant strains of S. aureus (MRSA). The primary active component, terpinen-4-ol, is believed to disrupt bacterial cell membranes, leading to cell death.

Small clinical studies and case reports have evaluated topical tea tree oil for minor skin infections, including staph-related impetigo and wound colonization. Some randomized controlled trials have shown that tea tree oil preparations can reduce bacterial load in wounds or on the skin, although results are mixed and studies are often limited by small sample sizes or methodological issues. Notably, a few hospital-based studies have investigated tea tree oil-based body washes for MRSA decolonization with some positive results, but larger, high-quality trials are lacking.

Major health organizations do not currently recommend tea tree oil as a sole or primary treatment for staph infections, especially serious or systemic infections. However, the available scientific evidence supports its use as an adjunct or topical agent for minor staph skin infections, and more robust clinical studies are warranted. Tea tree oil can cause skin irritation in some people and should not be ingested.

More about Tea Tree
More about Staph Infections

Other ingredients used for Staph Infections

Other health conditions supported by Tea Tree

Products containing Tea Tree